We are live on ! Find out more
BDTX icon

Black Diamond Therapeutics
BDTX

88 hedge funds and large institutions have $717M invested in Black Diamond Therapeutics in 2020 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 18 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 18

73% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 11

10% more funds holding

Funds holding: 80 → 88 (+8)

1.75% more ownership

Funds ownership: 64.43% → 66.17% (+1.7%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

26% less capital invested

Capital invested by funds: $968M → $717M (-$251M)

Holders
88
Holders Change
+8
Holders Change %
+10%
% of All Funds
1.78%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
19
Increased
38
Reduced
18
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$24M
2
BlackRock
BlackRock
New York
+$10.5M
3
DM
Deerfield Management
New York
+$8.11M
4
PCM
Peregrine Capital Management
Minnesota
+$5.83M
5
IC
Ikarian Capital
Texas
+$5.52M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$44M
2
BI
BVF Inc
California
-$16M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$6.53M
4
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$4.51M
5
EA
Emerald Advisers
Pennsylvania
-$3.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
51
Tower Research Capital (TRC)
New York
$427K +$354K +11,644 +467%
New York State Common Retirement Fund
52
New York State Common Retirement Fund
New York
$402K +$73K +2,400 +22%
MFS
53
Mirabella Financial Services
United Kingdom
$389K +$391K +12,861 New
SEI Investments
54
SEI Investments
Pennsylvania
$330K +$333K +10,931 New
AIG
55
American International Group
New York
$327K +$100K +3,295 +44%
AC
56
Athanor Capital
New York
$309K -$230K -7,568 -43%
Manulife (Manufacturers Life Insurance)
57
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$303K +$89.8K +2,951 +42%
HLA
58
Hamilton Lane Advisors
Pennsylvania
$302K +$304K +9,981 New
PP
59
PDT Partners
New York
$302K +$305K +10,006 New
Deutsche Bank
60
Deutsche Bank
Germany
$300K -$175K -5,747 -37%
HP
61
Harbourvest Partners
Massachusetts
$290K +$292K +9,581 New
VEA
62
Virtus ETF Advisers
New York
$270K -$36.9K -1,214 -12%
Morgan Stanley
63
Morgan Stanley
New York
$257K +$143K +4,695 +123%
HTC
64
Hershey Trust Company
Pennsylvania
$250K +$251K +8,258 New
MIM
65
MetLife Investment Management
New Jersey
$246K +$55.7K +1,831 +29%
SSA
66
Schonfeld Strategic Advisors
New York
$244K +$247K +8,100 New
Goldman Sachs
67
Goldman Sachs
New York
$238K -$278K -9,145 -54%
AC
68
Amia Capital
United Kingdom
$229K +$82.3K +2,703 +55%
RJA
69
Raymond James & Associates
Florida
$227K +$10.1K +333 +5%
HA
70
HC Advisors
Georgia
$202K +$203K +6,675 New
WCA
71
Windsor Creek Advisors
Vermont
$196K +$198K +6,500 New
Russell Investments Group
72
Russell Investments Group
United Kingdom
$192K +$194K +6,367 New
MLICM
73
Metropolitan Life Insurance Company (MetLife)
New York
$169K +$34.3K +1,127 +25%
Citigroup
74
Citigroup
New York
$86K -$34.5K -1,133 -28%
EA
75
Emerald Advisers
Pennsylvania
$80K -$3.48M -114,307 -98%
1 2
3
4

BDTX Hedge Fund Activity: Q3 2020 in Review

88 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Black Diamond Therapeutics (BDTX) for Q3 2020, worth a combined $717M — down 26% from $968M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new BDTX positions and 11 closed out — a net gain of 8 holders — while 38 added to existing stakes and 18 trimmed.

The largest buyer was Vanguard Group, adding an estimated $24M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $44M sold.

  • 88 institutional investors held Black Diamond Therapeutics (BDTX) as of Q3 2020, up from 80 in Q2 2020.
  • Funds reported $717M of Black Diamond Therapeutics stock for Q3 2020, down 26% quarter-over-quarter.
  • 19 funds opened new Black Diamond Therapeutics positions in Q3 2020 and 11 closed out, a net change of +8 holders.
  • The largest Black Diamond Therapeutics buyer in Q3 2020 was Vanguard Group, an estimated $24M added.
  • The largest Black Diamond Therapeutics seller in Q3 2020 was Perceptive Advisors, an estimated $44M sold.

Based on aggregated 13F filings for Q3 2020.